Role of PD-1 and its ligand, B7-H1, in early fate decisions of CD8 T cells
about
Clinical utility of nivolumab in the treatment of advanced melanomaExploiting the Immunomodulatory Properties of Chemotherapeutic Drugs to Improve the Success of Cancer ImmunotherapyImpaired T-Cell Function in B-Cell Lymphoma: A Direct Consequence of Events at the Immunological Synapse?B7-H1 blockade increases survival of dysfunctional CD8(+) T cells and confers protection against Leishmania donovani infectionsAntigen-specific immunotherapy of cervical and ovarian cancerHigh-programmed death-1 levels on hepatitis C virus-specific T cells during acute infection are associated with viral persistence and require preservation of cognate antigen during chronic infectionCombination Approaches with Immune-Checkpoint Blockade in Cancer TherapySpecific CD8(+) T cell response immunotherapy for hepatocellular carcinoma and viral hepatitisImmune checkpoint blockade: a common denominator approach to cancer therapyHigh avidity cytotoxic T lymphocytes can be selected into the memory pool but they are exquisitely sensitive to functional impairmentPhase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlatesRegulation of T-cell Tolerance by Lymphatic Endothelial Cells.Control of pathogenic effector T-cell activities in situ by PD-L1 expression on respiratory inflammatory dendritic cells during respiratory syncytial virus infection.Lymphatic endothelial cells induce tolerance via PD-L1 and lack of costimulation leading to high-level PD-1 expression on CD8 T cells.Lymphatic endothelial cells - key players in regulation of tolerance and immunityBlockade of PD-1/B7-H1 interaction restores effector CD8+ T cell responses in a hepatitis C virus core murine modelA2A receptor signaling promotes peripheral tolerance by inducing T-cell anergy and the generation of adaptive regulatory T cells.DNA vaccines for cervical cancerMetastatic melanoma: New paradigms of treatment and new toxicitiesSelf-antigen prevents CD8 T cell effector differentiation by CD134 and CD137 dual costimulation.Breathing new life into immunotherapy: review of melanoma, lung and kidney cancerPerspectives for preventive and therapeutic HPV vaccines.Immunotherapy for cervical cancer: Research status and clinical potentialB7-H1/CD80 interaction is required for the induction and maintenance of peripheral T-cell toleranceLAG-3, TGF-β, and cell-intrinsic PD-1 inhibitory pathways contribute to CD8 but not CD4 T-cell tolerance induced by allogeneic BMT with anti-CD40L.Perspective for prophylaxis and treatment of cervical cancer: an immunological approach.Immune inhibitory molecules LAG-3 and PD-1 synergistically regulate T-cell function to promote tumoral immune escapePD-1, PD-L1 (B7-H1) and Tumor-Site Immune Modulation Therapy: The Historical Perspective.PD-1 on dendritic cells impedes innate immunity against bacterial infection.LAG-3 regulates CD8+ T cell accumulation and effector function in murine self- and tumor-tolerance systems.Tc17 CD8 T cells: functional plasticity and subset diversity.Functionally distinct LAG-3 and PD-1 subsets on activated and chronically stimulated CD8 T cellsCyclophosphamide augments antitumor immunity: studies in an autochthonous prostate cancer model.Blockade of PD-1/PD-L1 promotes adoptive T-cell immunotherapy in a tolerogenic environment.DNA vaccines for cervical cancer: from bench to bedside.B7-h1 expressed by activated CD8 T cells is essential for their survival.Anti-tumor effects of endogenous prostate cancer-specific CD8 T cells in a murine TCR transgenic modelElevated tumor-associated antigen expression suppresses variant peptide vaccine responses.Anti-PD-1/PD-L1 therapy of human cancer: past, present, and future.Subset- and Antigen-Specific Effects of Treg on CD8+ T Cell Responses in Chronic HIV Infection
P2860
Q26751268-D4EC8B7E-6F0D-45DA-8FEB-CBFC7293BB46Q26779184-54D6E306-8A66-460B-BCA0-D78E64A5C89BQ27003955-3723F8FA-63F4-49D8-8259-CCCF525A50BCQ27317015-BACD7F21-21F2-461B-B32C-D0F6BB307072Q27488697-F1D9BE26-B95C-4C04-9933-A4712666A1E7Q27490345-92ECF5E6-4865-480B-879C-2CD230C55ABEQ28066199-69439952-7422-494E-8EB2-3B0E68005B99Q28074434-4F4EF4DC-DE81-433E-8EFA-F4F3626F744BQ28083981-DCD02CB7-B3C7-43A0-9F3D-A96F082839DCQ28729034-B10B07D0-962C-441B-B130-A81F998454CFQ29620051-8F707B29-5CF4-468F-B331-A02527371CD4Q30300970-984DBA1D-58D9-4CD9-ADA9-5470BEF59392Q30301182-86773684-0D61-42D8-9D39-5F376ADB30D7Q30415907-1026038A-C288-4E1B-AEBB-C471299D9A3CQ30424567-FEFAD5D9-3FA1-4CBD-B454-00D7E6011F04Q30435498-5ADBD242-F9B5-4A34-981E-D2EDEA39ECEDQ30440525-27674EC7-5BAE-454E-9CCD-A0D268A150CCQ33680693-9D7CF95D-65E5-455C-A928-C30094AD7016Q33697326-C11AFFD7-002A-446F-859F-7E1443EF730BQ33756678-CD824460-1470-4EF4-AADE-76290518871DQ33862861-51BF5623-5A05-4619-854F-E9DAE1AAE943Q34011494-D608D37F-E8F9-45A3-A4E8-812CAF2A2946Q34033763-D164EA73-930D-44C2-AA67-23BFA557E33EQ34122678-B55A9BB4-967A-44EB-A52E-650266A4C3C4Q34172252-8F264CF4-6ADA-4955-B0E6-3A0E096E0609Q34181909-2D5A65E4-AC48-4AF2-B465-8A644D8807A7Q34241893-84D5B68C-6F14-41C5-A9B8-94DACE743E8BQ34550012-1CEA3B0A-FC19-4DF3-9DFD-DF43502A43BCQ34606110-9D95C922-F8F7-49FA-9B62-AC721B20F781Q34700552-7E52E7E9-FDC6-4E64-9FE3-F859D19A42D6Q34856750-0EAB829A-80F2-493D-B089-9FB0AFA169BAQ34856800-482A4558-5D15-4676-AD44-2A0EF9DBA8B7Q34887495-DFC5E435-7E94-45F5-8412-0AEBA9D470CAQ35151883-4B1CAE40-41C6-4A25-A038-653517A8FD53Q35234992-A342CCDD-3054-455C-B088-E842E6924430Q35566744-C604C65C-DEBB-448B-8B8C-A113F1B6EAB1Q35641792-42B99EA2-145B-4F63-BCB8-722D6AB9F208Q35906719-0ACDB0AC-609B-449A-B5E6-68E9B66E5175Q36106006-18E1AF3F-A580-4E00-9E18-4573150ABE7DQ36187428-6DA33ECC-6565-420F-8D1C-9AB0EB1AA33B
P2860
Role of PD-1 and its ligand, B7-H1, in early fate decisions of CD8 T cells
description
2007 nî lūn-bûn
@nan
2007 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մարտին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Role of PD-1 and its ligand, B7-H1, in early fate decisions of CD8 T cells
@ast
Role of PD-1 and its ligand, B7-H1, in early fate decisions of CD8 T cells
@en
Role of PD-1 and its ligand, B7-H1, in early fate decisions of CD8 T cells
@nl
type
label
Role of PD-1 and its ligand, B7-H1, in early fate decisions of CD8 T cells
@ast
Role of PD-1 and its ligand, B7-H1, in early fate decisions of CD8 T cells
@en
Role of PD-1 and its ligand, B7-H1, in early fate decisions of CD8 T cells
@nl
prefLabel
Role of PD-1 and its ligand, B7-H1, in early fate decisions of CD8 T cells
@ast
Role of PD-1 and its ligand, B7-H1, in early fate decisions of CD8 T cells
@en
Role of PD-1 and its ligand, B7-H1, in early fate decisions of CD8 T cells
@nl
P2093
P2860
P1433
P1476
Role of PD-1 and its ligand, B7-H1, in early fate decisions of CD8 T cells
@en
P2093
Charles G Drake
Charles H Maris
Derese Getnet
Dirk G Brockstedt
Drew M Pardoll
Edward L Hipkiss
Joseph F Grosso
Katharine A Whartenby
Lijie Zhen
Monica V Goldberg
P2860
P304
P356
10.1182/BLOOD-2006-12-062422
P407
P577
2007-03-28T00:00:00Z